You have 9 free searches left this month | for more free features.

stage III endometrial carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma Trial in United States (Intensity-modulated

Recruiting
  • Endometrial Cancer
  • +4 more
  • Intensity-modulated radiation therapy
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 10, 2023

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

Not yet recruiting
  • Metastatic Endometrial Carcinoma
  • +7 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV Trial in Boston (Exercise, Attention Control)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Exercise
  • Attention Control
  • Boston, Massachusetts
    Dana Farber Cancer Institute
May 4, 2022

Endometrial Cancer, Papillary Serous Endometrial Carcinoma, Uterine Serous Carcinoma Trial in United States (Niraparib)

Recruiting
  • Endometrial Cancer
  • +4 more
  • New Brunswick, New Jersey
  • +4 more
Mar 17, 2022

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Bile Duct Carcinoma
  • +33 more
  • Sacramento, California
  • +6 more
Aug 11, 2022

Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Breast Cancer Stage IV Trial in Pittsburgh (Strong Together serious game)

Completed
  • Ovarian Cancer Stage III
  • +12 more
  • Strong Together serious game
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Dec 14, 2021

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Among Reproductive Age Gynecological and Breast Cancer

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +29 more
  • Healthcare Activity
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Ovarian Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial in Prague (other, behavioral, dietary supplement)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Physiological intervention
  • +2 more
  • Prague, Czechia
    Gynecologic Oncology Center in Prague
Mar 29, 2022

Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma Trial in Canada, United States

Active, not recruiting
  • Advanced Endometrial Carcinoma
  • +4 more
  • Cabozantinib S-malate
  • Nivolumab
  • Phoenix, Arizona
  • +33 more
Nov 1, 2022

Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma Trial in Cleveland (lymph node

Terminated
  • Stage I Endometrial Carcinoma
  • +3 more
  • lymph node mapping
  • +5 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 26, 2020

Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston

Recruiting
  • Advanced Endometrial Carcinoma
  • +36 more
  • Glutaminase Inhibitor IPN60090
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 9, 2021

Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet

Recruiting
  • Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
  • statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 22, 2023

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma Stage I
  • Medroxyprogesterone acetate + Atorvastatin
  • Peking, Beijing, China
    Wang Jianliu
Dec 29, 2022

Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended

Recruiting
  • Endometrial Neoplasms
  • +4 more
  • Indication-extended Fertility-sparing Therapy
  • Beijing, Beijing, China
    Peking University People's Hosoital
Jul 12, 2023

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication

Active, not recruiting
  • Cancer Survivor
  • +6 more
  • Communication Intervention
  • +5 more
  • Palo Alto, California
  • +1 more
Oct 24, 2022

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 11, 2023

Endometrial Cancer Trial in Detroit (Quality of life questionnaire)

Recruiting
  • Endometrial Cancer
  • Quality of life questionnaire
  • Detroit, Michigan
    Henry Ford Cancer Institute
Feb 22, 2022

Advanced Endometrial Adenocarcinoma, Stage III A, B, C Trial in Greenville, Roanoke (Docetaxel and Carboplatin)

Terminated
  • Advanced Endometrial Adenocarcinoma, Stage III A, B, C
  • Docetaxel and Carboplatin
  • Greenville, South Carolina
  • +1 more
Feb 3, 2021

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Endometrial Cancer Trial in Baltimore, Syracuse, Charlottesville (HDR vaginal brachytherapy)

Recruiting
  • Endometrial Cancer
  • HDR vaginal brachytherapy
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023